Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

被引:102
作者
Moore, JP
Parren, PWHI
Burton, DR
机构
[1] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA
[2] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1128/JVI.75.13.5721-5729.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:5721 / 5729
页数:9
相关论文
共 141 条
  • [11] A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
    Binley, JM
    Sanders, RW
    Clas, B
    Schuelke, N
    Master, A
    Guo, Y
    Kajumo, F
    Anselma, DJ
    Maddon, PJ
    Olson, WC
    Moore, JP
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (02) : 627 - 643
  • [12] CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION
    BOUHABIB, DC
    RODERIQUEZ, G
    ORAVECZ, T
    BERMAN, PW
    LUSSO, P
    NORCROSS, MA
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (09) : 6006 - 6013
  • [13] T lymphocyte responses in HIV-1 infection: implications for vaccine development
    Brander, C
    Walker, B
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (04) : 451 - 459
  • [14] GENERATION OF HUMAN MONOCLONAL-ANTIBODIES AGAINST HIV-1 PROTEINS - ELECTROFUSION AND EPSTEIN-BARR-VIRUS TRANSFORMATION FOR PERIPHERAL-BLOOD LYMPHOCYTE IMMORTALIZATION
    BUCHACHER, A
    PREDL, R
    STRUTZENBERGER, K
    STEINFELLNER, W
    TRKOLA, A
    PURTSCHER, M
    GRUBER, G
    TAUER, C
    STEINDL, F
    JUNGBAUER, A
    KATINGER, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 359 - 369
  • [15] EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY
    BURTON, DR
    PYATI, J
    KODURI, R
    SHARP, SJ
    THORNTON, GB
    PARREN, PWHI
    SAWYER, LSW
    HENDRY, RM
    DUNLOP, N
    NARA, PL
    LAMACCHIA, M
    GARRATTY, E
    STIEHM, ER
    BRYSON, YJ
    CAO, YZ
    MOORE, JP
    HO, DD
    BARBAS, CF
    [J]. SCIENCE, 1994, 266 (5187) : 1024 - 1027
  • [16] Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection?
    Burton, DR
    Parren, PWHI
    [J]. NATURE MEDICINE, 2000, 6 (02) : 123 - 125
  • [17] A vaccine for HIV type 1: The antibody perspective
    Burton, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) : 10018 - 10023
  • [18] Burton DR, 1997, AIDS, V11, pS87
  • [19] Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda
    Cao, HY
    Mani, I
    Vincent, R
    Mugerwa, R
    Mugyenyi, P
    Kanki, P
    Ellner, J
    Walker, BD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) : 1350 - 1356
  • [20] EFFECTS OF AMINO-ACID CHANGES IN THE EXTRACELLULAR DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 ENVELOPE GLYCOPROTEIN
    CAO, J
    BERGERON, L
    HELSETH, E
    THALI, M
    REPKE, H
    SODROSKI, J
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (05) : 2747 - 2755